References
- Kubota T., Kumasaka T., Suzuki A., Yaoui Y., Saito M. The determination of dopamine in decidual and villous tissue in early pregnancy. Nippon-Naibunpi-Gakkai-Zasshi. 1979; 55: 183–193
- Chard T. Placental synthesis. Clinics in obstetrics and gynecology. The human placenta, T. Chard. Saunders, Philadelphia 1986; 447–467, (Guest Ed.)
- Petit A., Guillon G., Pantaloni C., Tencé M., Gallo-Payet N., Bellabarba D., Lehoux J.-G., Bélisle S. An islet-activating protein-sensitive G-protein is involved in dopamine inhibition of both angiotensin-stimulated inositol phosphate production and human placental lactogen release in human trophoblastic cells. J. Clin. Endocrinol. Metab. 1990; 71: 1573–1580
- Petit A., Gallo-Payet N., Vaillancourt C., Bellabarba D., Lehoux J.-G., Bélisle S. A role for extracellular calcium in the regulation of placental lactogen release by angiotensin II and dopamine in human term trophoblastic cells. J Clin Endocrinol Metab., (submitted for publication)
- Petit A., Vaillancourt C., Bellabarba D., Lehoux J.-G., Gallo-Payet N., Bélisle S. Presence of dopamine D2-receptors in human term placenta. J. Recept Res. 1990; 10: 205–215
- Leysen J. E., Niemegeers C. J.E., Tollenaere J. P., Laduron P. M. Serotonergic component of neuroleptic receptor. Nature 1978; 272: 168–171
- Withy R. M., Mayer R. J., Stange P. G. Use of [3H]spiperone for labelling dopaminergic and serotonergic receptors in bovine caudate nucleus. J. Neurochem. 1981; 37: 1144–1154
- Treiman M., Andersen P. H. Two classes of [3H]spiperone binding sites in bovine neurohypophysis: D2 receptors and 5-HT2 receptors. J. Recept Res. 1989; 9: 297–312
- Bélisle S., Petit A., Gallo-Payet N., Bellarbarba D., Lehoux J.-G., Lemaire S. Functional opioid receptor sites in human placentas. J Clin Endocrinol Metab. 1988; 66: 283–289
- Bélisle S., Guevin J. F., Bellabarba D., Lehoux J.-G. Lutenizing hormone releasing hormone binds enrichedhuman placerital membranes and stimulates in vitro the synthesis of bioactive human chorionic gonadotropin. J Clin Endocrinol Metab. 1984; 59: 119–126
- Hamblin M. W., Stuart E., Creese I. Interactions of agonists with D2-dopamine receptors: evidence for single receptor population existing in multiple agonist affinity states in rat striatal membranes. Biochem Pharmacol. 1984; 33: 877–887
- Hoyer D., Schoeffter P. 5-HT receptors: subtypes and second messengers. J Recept Res. 1991; 11: 197–214
- Pritchett D. B., Bach A. W.J., Wozny M., Taleb O., Dal Toso R., Shich J. C., Seeburg P. Structure and functional expression of cloned rat serotonin 5-HT2 receptor. Embo J. 1988; 7: 4135–4140
- Leysen J. E., Niemegeers J. E., Van Neuten J. M., Laduron P. M. [3H]ketanserin (R21468), a selective 3H-ligand for serotonin 2 receptor binding sites, Binding properties, brain distribution, and functional role. Mol Pharmacol. 1982; 21: 301–314
- Hietala J., Syvalahti E., Roytla M. Comparison of neuroleptic binding characteristics in rat striatum and renal cortex. J Recept Res. 1988; 8: 753–771
- Huo T., Ye M. Q., Healy D. P. Characterization of a dopamine receptor (DA2k) in kidney inner medulla. Proc Natl Acad Sci USA 1991; 88: 3170–3174
- Andersen P. H., Gingrich J. A., Bates M. D., Dearry A., Falardeau P., Senogles E., Caron M. G. Dopamine receptor subtypes: beyong the D1/D2 classification. Trends Pharmacol Sci. 1990; 11: 231–236
- Sibley D. R., Monsma F. J., Jr. Molecular biology of dopamine receptors. Trends Pharmacol Sci. 1992; 13: 61–69
- Köhler C., Hall H., Ögren S. O., Gawell L. Specific in vitro binding of 3H-raclopride. Biochem Pharmacol. 1985; 34: 2251–2259
- Hall H., Köhler C., Gawell L., Farde L., Sedvall G. Raclopride, a new selective ligand for the dopamine-D2 receptors. Prog Neuro-Psychopharmacol Biol Psychiatr. 1988; 12: 559–568
- Lidow M. S., Goldman-Rakic P. S., Rakic P., Innis R. B. Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]-raclopride. Proc Natl Acad Sci USA 1989; 86: 6412–6416
- Hall H., Högherb C., Halldin C., Köhler C., Ström P., Ross S. B., Larsson S. A., Farde L. NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors. Psychopharmacology 1991; 103: 6–18
- Sibley D. R., De Lean A., Creese I. Anterior pituitary dopamine receptors Demonstration of interconvertible high and low affinity states of the D2 dopamine receptor. J Biol Chem. 1982; 257: 6351–6361
- Hoffman B. B., Mullikin-Kilpatrick D., Lefkowitz R. J. Heterogeneity of radioligand to α-adrenergic receptors: analysis of guanine nucleotide regulation of agonist binding in relation to receptor subtype. J Biol Chem. 1980; 255: 4645
- De Lean A., Stadel J. M., Lefkowitz R. J. A ternary complex model explains the agonist specific binding properties of adenylate cyclase-coupled β-adrenergic receptor. J Biol Chem. 1980; 255: 7108
- Lamed J., Cone R. I., Meada S., Philip M., Corbani M., Nadasai Lé., Ramachandran J., Smith G. M., Sadée W. Structure and function of G protein coupled receptors. Pharm Res. 1990; 7: 1213–1221